Replimune Group (REPL) Short Interest
Nasdaq • REPL • US76029N1063
As of Oct 22, 2026, ORTEX estimated 28.5% of free float sold short, 9.7 days to cover, cost to borrow 0.45%. Sign up for live short interest data.
Nasdaq • REPL • US76029N1063
As of Oct 22, 2026, ORTEX estimated 28.5% of free float sold short, 9.7 days to cover, cost to borrow 0.45%. Sign up for live short interest data.
This page tracks how heavily Replimune Group (Nasdaq:REPL) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Replimune Group (Nasdaq: REPL) has a market capitalization of $2.05B. Last close $21.62 (as of 2026-11-09); 52-week range $1.50 to $21.91. ORTEX data as of 2026-10-22: short interest was 28.47% of free float, 9.7 days to cover and the average cost to borrow was 0.45%. Sign up for live short interest data.